Therapeutic compositions for intranasal administration of ketorolac

Details for Australian Patent Application No. 2005322305 (hide)

Owner Roxro Pharma, Inc.

Inventors Thirucote, Ramachandran; Whiting, Roger

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005322305

PCT Pub. Number WO2006/071601

Priority 60/639,022 23.12.04 US

Filing date 15 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 16 September 2010

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/071601 Priority application(s): WO2006/071601

16 September 2010 Application Accepted

  Published as AU-B-2005322305

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322308-Optical substrate and method of making

2005322301-Preloaded IOL injector and method